Resverlogix Corp. Stock OTC Markets
Stocks
RVXCF
CA76128M1086
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0714 USD | -3.00% |
|
-2.99% | -3.77% |
| 06-26 | Resverlogix Corp. - Shareholder/Analyst Call | |
| 05-16 | Resverlogix Corp. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Market Cap | 23.28M 16.6M 14.43M 13.43M 12.33M 1.58B 23.65M 158M 62.13M 789M 62.33M 60.96M 2.64B | P/E 2024 |
-1.38x | P/E 2025 | -2.68x |
|---|---|---|---|---|---|
| Enterprise Value | 109M 77.75M 67.59M 62.91M 57.76M 7.42B 111M 742M 291M 3.7B 292M 286M 12.39B | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
60.4% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Resverlogix Corp.
| 1 day | -3.00% | ||
| 1 week | -2.99% | ||
| 1 month | +6.09% | ||
| 3 months | -6.79% | ||
| 6 months | -10.64% | ||
| Current year | -3.77% |
| 1 week | 0.06 |  | 0.07 |
| 1 month | 0.06 | | 0.08 |
| Current year | 0.05 | | 0.1 |
| 1 year | 0.05 | | 0.1 |
| 3 years | 0.02 | | 0.21 |
| 5 years | 0.02 | | 0.65 |
| 10 years | 0.02 | | 4.14 |
| Manager | Title | Age | Since |
|---|---|---|---|
Donald McCaffrey
CEO | Chief Executive Officer | - | 25/04/2003 |
Anthony Cann
DFI | Director of Finance/CFO | 78 | 29/10/2009 |
| Chief Tech/Sci/R&D Officer | - | 15/08/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Donald McCaffrey
CHM | Chairman | - | 04/04/2016 |
Kelly McNeill
BRD | Director/Board Member | 56 | 15/10/2009 |
Kenneth Zuerblis
BRD | Director/Board Member | 66 | 29/09/2010 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.00% | -2.99% | - | - | 23.28M | |
| +2.35% | +2.74% | +33.41% | +79.20% | 56.54B | |
| -0.21% | -7.38% | +25.34% | +63.02% | 53.6B | |
| -2.44% | +1.40% | -15.74% | -16.80% | 22.91B | |
| -2.85% | -7.78% | -8.09% | +346.36% | 21.37B | |
| +2.49% | -0.92% | +20.31% | -12.15% | 20.27B | |
| +0.79% | -1.06% | +29.29% | -33.32% | 17.56B | |
| +0.58% | -5.88% | +16.30% | +540.37% | 14.75B | |
| -5.25% | -4.23% | +46.41% | +169.05% | 13.33B | |
| +3.41% | -6.61% | +163.08% | +280.43% | 13.53B | |
| Average | -0.41% | -3.79% | +34.48% | +157.35% | 25.98B | |
| Weighted average by Cap. | +0.23% | -2.96% | +28.67% | +119.98% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -7.64M -5.44M -4.73M -4.4M -4.04M -520M -7.75M -51.91M -20.37M -259M -20.44M -19.99M -867M | -7.77M -5.54M -4.81M -4.48M -4.11M -529M -7.89M -52.8M -20.72M -263M -20.79M -20.34M -882M |
| Net Debt | 81.87M 58.36M 50.73M 47.22M 43.35M 5.57B 83.14M 557M 218M 2.77B 219M 214M 9.3B | 85.79M 61.15M 53.16M 49.48M 45.43M 5.84B 87.12M 583M 229M 2.91B 230M 225M 9.75B |
Employees
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/07/26 | $0.0714 | -3.00% | 9,080 |
| 27/07/26 | $0.0736 | -.--% | 22,000 |
- Stock Market
- Stocks
- RVX Stock
- RVXCF Stock
Select your edition
All financial news and data tailored to specific country editions
